The Ott Lab, in collaboration with Drs Niren Murthy, and Nir Yusef at UC Berkeley as well as Dr. Steven Deeks at UCSF, was awarded an R61 grant by the National Institute of Health’s National Institute on Drug Abuse (NIDA). This grant will enable the Ott Lab to study primary latently infected T cells isolated from aviremic HIV-infected drug users using single-cell RNA-Seq and CRISPR technology.
In more good news, the Ott Lab’s recent R01 renewal ranked in the 3rd percentile during review at NIAID.